Breaking news and real-time updates from the ASX small-cap market
Entropy Neurodynamics reports durable 12-week BED response from TRP-8803, with 50% binge-free and 73% weekly episodes below baseline after two doses.
ECT adds defence rights to MXene strategy after Xenica sublicence; potential Xenica acquisition around 22 Oct 2026, with scale-up and defence trials ahead.
Sinclair Gold doubles Mt Henry resource to 1.8Moz (48Mt @1.2g/t), with 70% M&I; shallow, open-pit potential fuels expansion across Mt Henry corridor.
Adisyn wins US patent allowance extending graphene deposition to non-metallic surfaces, enabling low-temp barrier graphene in semiconductors.
dorsaVi begins energy benchmarking for its RRAM tech, targeting lower-power memory updates for ultra-edge AI, robotics and CIM-ready hardware.
Early access to super sparks inflation fears; COVID-era withdrawals showed debt risk, higher spending, and a booming property market—flashpoints in the debate.
ASX 200 falls as bond yields spike and oil surges, dragging miners lower while banks cling to gains amid rate-hike fears.
Buru Energy books maiden 2P reserves of 15.25 MMboe for Rafael gas field; aims first LNG/LPG sales by 2029 as financing and FID momentum builds.
Immutep refocuses eftilagimod alfa on HNSCC (CPS<1) and neoadjuvant STS after TACTI-004 review; new 200L manufacturing, target H2 2027 trial start.
Invictus Energy secures SLB drilling contract for Musuma-1 at Cabora Bassa, advancing prep ahead of Nov 2026 spud.
Resolution Minerals completes largest 12,236m drill program at Horse Heaven's Golden Gate; assays pending as gold/tungsten potential expands.
Impact Minerals and Kuniko extend Silica Hill; Phase 2 drilling yields ~100m vertical continuity; assays in 4–6 weeks; resource update due Dec 2026.
